) was isolated from calf lenses and its chemical structure was determined by comparison with the synthetic compound.
Determination of the Levels of GSH, and DCE-GS and Its Esters in Hepatocytes
For determination of the levels of these peptides in hepatocytes, cells that had been cultured in 16-mm dishes were washed three times with ice-cold phosphate buffered saline (PBS), and then 250 ml of 2% perchloric acid was added to the cell pellet, followed by keeping at 4°C for 30 min. Two hundred microliters of the perchloric acid solution was transferred to an Eppendorf tube and then neutralized with 40 ml of 4 M KH 2 PO 4 , followed by centrifugation at 5000ϫg for 5 min. The supernatant was used for determination of GSH, and DCE-GS and its esters. GSH was determined by the enzymatic recycling method using glutathione reductase and 5,5Ј-dithiobis-(2-nitrobenzoic acid). 11) DCE-GS and its esters were determined by HPLC after derivatization with 2,4-dinitrofluorobenzene. 4) Assaying of g g-GCS Activity in Hepatocytes Hepatocytes, which had been cultured in 35 mm dishes, were washed three times with ice-cold PBS and then scraped off the dishes with a silicon policeman. The hepatocytes were homogenized in 1.2 ml of 150 mM KCl, 1 mM MgCl 2 containing 5 mM 2-mercaptoethanol using a Potter-Elvehjem homogenizer with a Teflon pestle. After centrifugation at 15000ϫg for 20 min at 4°C, the supernatant was used as the enzyme solution.
The activity was determined by measuring the rate of formation of ADP spectrophotometrically by means of a coupled assay involving pyruvate kinase and lactate dehydrogenase.
12) The reaction mixture (1 ml) contained 100 mM TrisHCl (pH 8.0), 10 mM L-glutamate, 10 mM L-a -aminobutyrate, 20 mM MgCl 2 , 5 mM ATP, 2 mM phosphoenolpyruvate, 150 mM KCl, 0.2 mM NADH, pyruvate kinase (5 units; pig heart, EC. 2.7.1.40), and lactate dehydrogenase (10 units; pig heart, EC. 1.1.1.27). The reaction was initiated by adding the enzyme solution, and then the rate of the decrease in absorbance at 340 nm was followed at 37°C.
Hepatotoxicity Induced by APAP Hepatotoxicity was induced by the addition of 2 mM APAP to the culture medium. APAP was dissolved directly in the medium. The degree of hepatotoxicity was determined by measurement of aspartate aminotransferase (AST) leakage into the medium. AST activity was assayed using a commercially available kit (Transaminase CII-test Wako). DCE-GS and its esters were added to the medium 1 h prior to exposure to 2 mM APAP. After incubation for various periods of time the levels of intracellular GSH, and DCE-GS and its esters were determined.
Protein Determination Protein concentrations were determined with Bio-Rad Protein Assay Dye Reagent Concentrate using bovine serum albumin as a standard.
RESULTS

Protection against APAP-Induced Hepatotoxicity by DCE-GS Triester
The protective effect of DCE-GS triester against APAP-induced hepatotoxicity was examined. The degree of hepatotoxicity was judged as AST activity in the culture medium. As shown in Fig. 2 a marked increase of AST activity in the culture medium (about 12.5-fold over the control) was observed on APAP treatment of hepatocytes. The addition of 0.5 mM DCE-GS triester reduced the AST activity leakage induced by 2 mM APAP to the control level. This protection by DCE-GS triester was dose-dependent (data not shown).
Effect of DCE-GS Triester on the GSH Concentration in Hepatocytes
Previously we reported that DCE-GS triester pretreatment significantly prevented the hepatic GSH depletion produced by APAP. 9) Therefore, the effect of DCE-GS triester on the GSH content of rat hepatocytes was examined. After rat hepatocytes had been treated with DCE-GS triester for 5, 10, 20, 22 or 24 h, the cellular GSH content was determined ( Fig. 3(a) ). The treatment with DCE-GS triester (0.25, 0.5 or 1 mM) caused dose-and time-dependent increases in the intracellular GSH content. In the same manner, the elevating effect of DCE-GS triester on the GSH content of APAP-treated hepatocytes was examined. As shown in Fig. 3 (b) treatment with APAP significantly decreased the GSH content of hepatocytes. The addition of DCE-GS triester to the culture medium prevented the GSH depletion caused by APAP in dose-and time-dependent manners. Table  1 summarizes the effects of GSH, and DCE-GS and its esters on the GSH level in rat hepatocytes. DCE-GS monoester, diester and triester at the concentration of 0.5 mM increased the GSH level in rat hepatocytes up to 122, 144 and 210% over the control level after 24 h, respectively, while GSH and DCE-GS had no elevating effect on the GSH level. DCE-GS triester increased the GSH level much more effectively than GSH, DCE-GS, and DCE-GS monoester and diester.
Effects of DCE-GS Triester on the g g-Glutamylcysteine Synthetase (g g-GCS) Activity in Hepatocytes It was shown that the treatment with DCE-GS triester caused the elevation of the GSH content in hepatocytes. In order to clarify the mechanism of the elevation of GSH content by DCE-GS triester treatment, the effect of DCE-GS triester on the activity of g-GCS, the rate-limiting enzyme in the GSH synthesis, in hepatocytes was examined. As shown in Table 2 , with 0.5 and 1 mM DCE-GS triester, the increases in the g-GCS activity reached 139 and 150%, respectively.
Effects of DCE-GS and Its Esters on the g g-GCS Activity in a Rat Liver Homogenate The effects of DCE-GS 750
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Fig. 2. Effect of DCE-GS Triester on APAP-Induced Hepatotoxicity
Hepatocytes were treated with 2 mM APAP (᭺), 2 mM APAP and 0.5 mM DCE-GS triester (ᮀ), or nothing (᭹) for various periods. DCE-GS triester was added to the medium 1 h prior to exposure to 2 mM APAP. The degree of hepatotoxicity was determined by measurement of AST leakage into the medium. Values are meansϮS.D. for six experiments.
and its esters at concentrations of 0.1 mM on the g-GCS activity were examined. A rat liver homogenate 15000ϫg supernatant was used as the g-GCS enzyme source. As shown in Table 3 , DCE-GS increased the g-GCS activity up to 300%, while DCE-GS triester had no effect on this activity.
The Levels of DCE-GS and Its Esters in Rat Hepatocytes after Treatment with DCE-GS Triester DCE-GS
and its esters in rat hepatocytes were assayed 24 h after treatment with DCE-GS triester. On treatment with DCE-GS triester, the levels of DCE-GS and its monoester in rat hepatocytes were significantly increased up to 5.54Ϯ0.38 and 3.15Ϯ0.54 nmol/mg protein, respectively. However, the increases in DCE-GS diester and triester were slight. In rat hepatocytes treated with bis-(p-nitrophenyl)phosphate, a nonspecific esterase inhibitor, the increase in the DCE-GS level caused by DCE-GS triester treatment was not observed (data not shown). These results show that DCE-GS triester was transported into hepatocytes and then converted to DCE-GS via its diester and monoester. The conversion of DCE-GS monoester to DCE-GS was significantly slower than those of DCE-GS triester to the diester and the diester to the monoester by esterase.
DISCUSSION
The present study showed the mechanism of the enhance- Hepatocytes were incubated in the culture medium containing GSH, or DCE-GS or one of its esters at the concentration of 0.5 mM. After incubation for 24 h, the GSH level in hepatocytes was measured as described under Materials and Methods. Values are meansϮS.D. for six experiments. Rat liver (1 g) was homogenized in 5 volumes of 150 mM KCl, 1 mM MgCl 2 containing 5 mM 2-mercaptoethanol. After centrifugation at 15000ϫg for 20 min at 4°C, the supernatant was dialyzed against 50 mM Tris-HCl (pH 7.4) containing 5 mM 2-mercaptoethanol and 5 mM MgCl 2 . The dialyzed solution was centrifuged at 15000ϫg for 20 min and the supernatant was used as the g-GCS enzyme solution. The g-GCS activity was measured as described under Materials and Methods. DCE-GS and its esters were each added the reaction mixture at the concentration of 0. In a previous paper we reported that pretreatment with DCE-GS triester markedly prevented APAP-induced liver injury in rats. 9) Furthermore, in this study the protective effect of DCE-GS triester against APAP-induced hepatotoxicity was demonstrated using rat hepatocytes (Fig. 2) . The hepatotoxicity of APAP is known to involve the formation of a chemically reactive metabolite, N-acetyl-p-benzoquinonimine (NAPQI), which is produced during cytochrome P-450-mediated oxidation of the drug. NAPQI has been reported to be highly reactive both as an electrophile and as an oxidant species, 13) and it irreversibly arylates protein thiol residues. 14) Several studies have shown that intracellular GSH is of major importance in protecting cells against damage due to toxic and reactive oxygen compounds. 15, 16) The hepatotoxicity of APAP is prevented by compounds such as N-acetylcysteine or 2-oxothiazolidine-4-carboxylate, which act to maintain the GSH level in the liver and to promote the redox cycle of GSH. 17, 18) Hence, we determined the GSH level in rat hepatocytes after treatment with DCE-GS triester. As shown in Figs. 3(a) and (b) treatment with DCE-GS triester significantly prevented the GSH depletion caused by APAP and also increased the hepatic GSH level.
With respect to the elevating effect of DCE-GS triester on the GSH level, it was examined whether or not other peptides caused elevation of the GSH level. DCE-GS triester elevated the GSH level in rat hepatocytes much more effectively than GSH, and DCE-GS and its esters (Table 1 ). This elevation of the GSH level in rat hepatocytes caused by DCE-GS esters was lipophilicity-dependent. That is to say, this strong elevating effect of DCE-GS triester on the GSH level is probably due to its easy transport into hepatocytes because of its greater lipophilicity.
Next, we examined the effects of DCE-GS esters on GSH synthesis. The synthesis of GSH is catalyzed by two enzymes, g-GCS and GSH synthetase. The former is the ratelimiting enzyme and its feedback is inhibited by GSH. 19) This feedback inhibition by GSH, which is not allosteric in nature, appears to involve the binding of GSH to the glutamate site of the enzyme as well as to another enzyme site: this site may require a sulfhydryl group since ophthalmic acid (g-glutamyl-a-aminobutyryl-glycine) is a weak inhibitor.
12) Kondo et al. previously showed the significance of glutathione S-conjugate in the regulation of GSH synthesis using human erythrocyte g-GCS. They reported that feedback inhibition of g-GCS by GSH was abolished by the addition of a glutathione S-conjugate such as S-2,4-dinitrophenyl glutathione. 20) As shown in Table 2 , treatment with DCE-GS triester increased the g-GCS activity in rat hepatocytes, whereas in experiments involving a rat liver homogenate 15000ϫg supernatant DCE-GS esters showed no effect on the g-GCS activity (Table 3) . Furthermore, treatment with DCE-GS triester significantly increased the DCE-GS and DCE-GS monoester levels in rat hepatocytes (Table 4) . However, the elevations of the g-GCS activity, and DCE-GS and DCE-GS monoester induced by the treatment with DCE-GS triester did not occur on treatment with bis-(p-nitrophenyl)-phosphate, a non-specific esterase inhibitor (data not shown). Nishida et al. elucidated the mechanism of conversion of gglutamylcysteinylethyl ester to GSH using isolated rat hepatocytes. 21) They reported that g-glutamylcysteinylethyl ester was transported into liver cells more easily than GSH itself, resulting in its conversion to GSH via esterase and glutathione synthetase within the cells, and also reported that the elevation of the intracellular GSH concentration induced on treatment with g-glutamylcysteinylethyl ester was markedly reduced by treatment with bis-(p-nitrophenyl)phosphate. From this evidence it was assumed that the DCE-GS triester transported into hepatocytes was hydrolyzed to DCE-GS via the di-and monoester by esterase.
In general, tripeptides such as GSH are not efficiently transported into most animal cells. 22) However, Anderson et al. have shown that the mono ester of GSH acts as highly efficient delivery agent for GSH; the monoethyl ester of GSH was well transported into many animal tissues and hydrolyzed intracellularly to GSH. 22) It has also been reported that GSH ester was much more effectively transported into various human cells than either GSH or GSH monoester, and was then hydrolyzed intracellularly to GSH. In addition, they reported that the diester was rapidly split intracellularly into the monoester, and high levels of the monoester were found intracellularly. The monoester, which was converted to GSH intracellularly, was only exported; thus, the diester served as a monoester delivery compound, which is trapped as a monoester within the cells. 23) Figure 4 shows the expected mechanism of enhancement of the GSH level by DCE-GS triester. It is therefore concluded that DCE-GS triester is transported into hepatocytes much more effectively than DCE-GS and other DCE-GS esters due to its greater lipophilicity, and then hydrolyzed intracellularly to DCE-GS via the di and monoesters. The DCE-GS produced promotes hepatic GSH synthesis due to the activation of g-GCS.
GSH has important functions in metabolism, the transport of amino acids, and protection of cells against the toxic effects of oxygen and other xenobiotics compounds. 24) It is very interesting that an intrinsic tripeptide such as DCE-GS plays a role in stimulating GSH synthesis. 
